Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies-Reference-Cited by-同舟云学术

Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies

Published:2017-08 Issue:4 Volume:40 Page:329-335
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Jalal Shadia I.,Hanna Nasser,Zon Robin,Masters Gregory A.,Borghaei Hossein,Koneru Karuna,Badve Sunil,Prasad Nagendra,Somaiah Neeta,Wu Jingwei,Yu Zhangsheng,Einhorn Lawrence

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference30 articles.

1. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

2. Treatment options for small cell lung cancer—do we have more choice;Puglisi;Br J Cancer,2010

3. A small-cell lung cancer genome with complex signatures of tobacco exposure;Pleasance;Nature,2010

4. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group;Roth;J Clin Oncol,1992

5. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N Engl J Med,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring gene-drug interactions for personalized treatment of post-traumatic stress disorder;Frontiers in Computational Neuroscience;2024-01-11

2. Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted;Cancers;2022-02-23

3. Lung Cancer;Reference Module in Biomedical Sciences;2021